Dr. Wilson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 St. Luke's Blvd
Cancer Center, Anderson Campus
Easton, PA 18045Phone+1 484-503-4673Fax+1 484-503-4501
Summary
- Dr. Melissa Wilson is an oncologist affiliated with St. Luke's University Health Network and is at the Cancer Center at the Anderson Campus. She is currently the Director of the Melanoma Program and the HemOnc Fellowship Program Director. She received her medical degree from Sidney Kimmel Medical College and has been in practice 7 years. She specializes in solid tumor oncology and skin cancers, predominantly melanoma, and is experienced in solid tumor oncology, cutaneous malignancies, and melanoma.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2010 - 2014- University of Pennsylvania Health SystemResidency, Internal Medicine, 2008 - 2010
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2008
Certifications & Licensure
PA State Medical License 2008 - 2024
NY State Medical License 2014 - 2019- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 136 citationsRelating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patientsBrandilyn A. Peters, Melissa Wilson, Una Moran, Anna C. Pavlick, Allison Izsak
Genome Medicine. 2019-10-09 - 36 citationsAssociation Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.Se Ryeong Jang, Nikita Nikita, Joshua Banks, Scott W. Keith, Jennifer Johnson
JAMA Network Open. 2021-12-01 - 29 citationsCopy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in MelanomaMelissa Wilson, Fengmin Zhao, Sanika Khare, Jason Roszik, Scott E. Woodman
Clinical Cancer Research. 2016-01-15
Press Mentions
Clinical Stage at Diagnosis Could Affect Melanoma SurvivalSeptember 7th, 2016
Professional Memberships
- Associate
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
